OMEGA THERAPEUTICS IN

Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results

14 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

15 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications

17 сен 2024 07:00:02 Источник Nasdaq GlobeNewswire

Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research

14 авг 2024 07:00:08 Источник Nasdaq GlobeNewswire

Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

06 авг 2024 07:00:09 Источник Nasdaq GlobeNewswire

Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

24 июн 2024 07:00:53 Источник Nasdaq GlobeNewswire

Omega Therapeutics To Participate In Two Upcoming Investor Conferences

30 май 2024 07:00:59 Источник Nasdaq GlobeNewswire

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

29 май 2024 07:00:17 Источник Nasdaq GlobeNewswire

Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers

08 май 2024 07:00:00 Источник Nasdaq GlobeNewswire

Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

06 май 2024 07:00:02 Источник Nasdaq GlobeNewswire

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting

23 апр 2024 07:00:02 Источник Nasdaq GlobeNewswire

Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control

09 апр 2024 07:00:31 Источник Nasdaq GlobeNewswire

Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update

28 мар 2024 09:15:05 Источник Nasdaq GlobeNewswire

Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024

06 мар 2024 07:00:08 Источник Nasdaq GlobeNewswire

Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

02 янв 2024 16:05:13 Источник Nasdaq GlobeNewswire

Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

04 дек 2023 16:00:22 Источник Nasdaq GlobeNewswire

Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference

20 ноя 2023 16:00:00 Источник Nasdaq GlobeNewswire

Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis

13 ноя 2023 07:00:32 Источник Nasdaq GlobeNewswire

Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

09 ноя 2023 07:00:17 Источник Nasdaq GlobeNewswire

Omega Therapeutics to Participate in The Jefferies London Healthcare Conference

07 ноя 2023 16:00:20 Источник Nasdaq GlobeNewswire